Baptist Memorial Health Care Corporation   Report issue

Academic/Hospital Phase 3
Founded: Memphis TN United States (1912)

Organization Overview

First Clinical Trial
2017
NCT03269994
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Baptist Memorial Health Care Corporation

Active Ingredients

Drugs in Phase 3 Trials (3)

cefoxitin (mefoxin) (1 trial)

piperacillin (pipracil) (1 trial)

tazobactam (Zosyn) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pancreatic Diseases (Phase 3)

Pancreatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3